Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

Share Price is delayed by 15 minutes
Get Live Data
131.60    -4.30 (-3.16%)
Bid:
131.30
Ask:
131.50
Spread: 0.20 (0.152%)
Market Cap: £332.80m
MSLH Live PriceLast checked at - London Stock Exchange

Intraday Marshalls Share Chart

Disposal

4 Jan 2005 14:00

Marshalls PLC04 January 2005 4 January 2005 MARSHALLS PLC SALE OF CLAY PRODUCTS DIVISION FOR £65 MILLION Marshalls plc ("Marshalls"), the specialist Landscape and Natural Stone ProductsGroup, is pleased to announce that, today, it has completed the unconditionalsale of the entire issued share capital of Marshalls Clay Products Limited (the"Clay Products Division") to Hanson PLC, for a cash consideration of £65 millionincluding the repayment of all intergroup indebtedness. The Clay Products Division manufactures and supplies a range of clay bricks andpavers from four facilities (three in Yorkshire and one in Lancashire) todomestic, commercial and public sector users based predominantly in the UK. For the year ended 31 December 2003, the Clay Products Division generated EBITAof £4.2 million, on turnover of £32.1 million. As at 31 December 2003, the ClayProducts Division had net operating assets, before intergoup indebtedness,of £37.1 million. In the year ended 31 December 2004, the Clay ProductsDivision achieved sales of £34 million. The proceeds from the sale will, initially, be used to reduce Group borrowings.The Group will, during 2005, review the acquisition and investment opportunitiesthat are available. In the absence of value adding opportunities the Group willconsider returning some or all of the proceeds to shareholders. Commenting on the sale, Graham Holden, Chief Executive, said: "Marshalls have improved the operating performance and reduced the capitalemployed in the Clay Products Division over the past two years. However, thebusiness is still only the fifth largest brick company in the UK with littleprospect of improving on this position. Having received a good offer we considerit is in the best interests of our shareholders to sell the business at thistime." Marshalls is today issuing a trading update for the year ended 31 December 2004. Enquiries: Graham Holden Chief Executive Marshalls plc 01484 438900Ian Burrell Finance Director Marshalls plc 01484 438900 James Fenwick Rothschild 0113 200 1900 Jon Coles Brunswick Group 0207 404 5959Sarah Tovey Brunswick Group 0207 404 5959 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Jun 20267:00 amRNSHolding(s) in Company
29th May 202612:17 pmRNSHolding(s) in Company
22nd May 20264:01 pmRNSDirector/PDMR Shareholding
22nd May 20263:58 pmRNSDirector/PDMR Shareholding
15th May 202611:04 amRNSDirector/PDMR Shareholding
15th May 202611:03 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
13th May 20263:08 pmRNSResult of AGM
13th May 20267:00 amRNSAGM Trading Update
15th Apr 202612:17 pmRNSDirector/PDMR Shareholding
15th Apr 202612:15 pmRNSDirector/PDMR Shareholding
17th Mar 20263:01 pmRNSDirector/PDMR Shareholding
17th Mar 20262:59 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSFinal Results
16th Mar 20267:00 amRNSFinal Results
11th Mar 20264:27 pmRNSDirector/PDMR Shareholding
11th Mar 20264:27 pmRNSDirector/PDMR Shareholding
11th Mar 20264:18 pmRNSDirector/PDMR Shareholding
11th Mar 20264:18 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS-RNotice of Engage Investor Presentation
13th Feb 20263:21 pmRNSDirector/PDMR Shareholding
13th Feb 20263:04 pmRNSDirector/PDMR Shareholding
13th Feb 20263:04 pmRNSDirector/PDMR Shareholding
19th Jan 20267:01 amRNSTrading Statement
19th Jan 20267:00 amRNSDirectorate change
9th Jan 202612:40 pmRNSDirector/PDMR Shareholding
9th Jan 202612:38 pmRNSDirector/PDMR Shareholding
6th Jan 20269:36 amRNSNotice of Trading Update
9th Dec 20253:21 pmRNSDirector/PDMR Shareholding
27th Nov 20257:00 amRNSBoard changes
12th Nov 20257:00 amRNSTrading Update
10th Nov 202510:30 amRNSDirector/PDMR Shareholding
10th Nov 202510:29 amRNSDirector/PDMR Shareholding
10th Nov 202510:27 amRNSDirector/PDMR Shareholding
30th Oct 20259:01 amRNSNotice of Trading Update
9th Oct 202512:45 pmRNSDirector/PDMR Shareholding
9th Oct 202512:44 pmRNSDirector/PDMR Shareholding
9th Oct 202512:42 pmRNSDirector/PDMR Shareholding
10th Sep 202512:06 pmRNSDirector/PDMR Shareholding
10th Sep 202512:05 pmRNSDirector/PDMR Shareholding
10th Sep 202512:04 pmRNSDirector/PDMR Shareholding
12th Aug 20259:28 amRNSDirector/PDMR Shareholding
11th Aug 20251:57 pmRNSDirector/PDMR Shareholding
11th Aug 20257:00 amRNSHalf year results
7th Aug 20257:00 amRNSDirectorate Change
28th Jul 202512:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.